Search
for
Sort by
Research 391–420 of 1000+
- Comparing the efficacy of oral apremilast, intralesional corticosteroids, and their combination in patients with patchy alopecia areata: a randomized clinical controlled trial
- Sexual Dysfunction in Alopecia Areata: A Systematic Review
- Association between alopecia areata and COVID-19: A systematic review
- Quality of life, psychosocial difficulties and bullying in paediatric patients with alopecia areata: a European cross-sectional study
- Alopecia areata: current concepts
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Cancer-Related Alopecia: From Etiologies to Global Management
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Insights into Alopecia Areata: A Systematic Review of Prevalence, Pathogenesis, and Psychological Consequences
- An Updated in the Management of Alopecia Areata
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Low-Dose Oral Minoxidil Beyond Androgenetic Alopecia: A Comparative Narrative Review of Emerging Evidence
- Exosome-Based Therapies for Alopecia Areata: A Systematic Review of Clinical and Experimental Evidence
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Nonscarring Alopecias
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Alopecia as an Emerging Adverse Effect Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss: A Scoping Review
- Diagnostic Challenges and Treatment Strategies in Neutrophilic Cicatricial Alopecias: A Narrative Review from Conventional Therapies to New Therapeutic Targets
- Red Blood Cells Folate Level in Patients with Alopecia Areata
- Novel Strategies for Androgenetic Alopecia Therapy: Integrating Multifunctional Plant Extracts with Nanotechnology for Advanced Cutaneous Drug Delivery
- How Our Microbiome Influences the Pathogenesis of Alopecia Areata
- Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Alopecia Areata after COVID-19 Vaccines
- Phytochemicals and novel delivery systems in alopecia management: An integrative review
- Exploring the Gut Microbiome and Metabolome in Individuals with Alopecia Areata Disease
- MicroRNA-1246 Inhibits NFATc1 Phosphorylation and Regulates T Helper 17 Cell Activation in the Pathogenesis of Severe Alopecia Areata